| | 133242-30-5 Basic information More.. |
| Product Name: | Landiolol | | Synonyms: | Landiolol;ONO-1101;ONO1101;ONO 1101;Landiolol D8;Landiolol HCL EP USP;Landiolol USP/EP/BP;((–)-[(S)-2,2-dimethyl-1,3-dioxolan-4-yl]methyl-3-{4-[(S)-2-hydroxy-3-(2-morpholino-carbonylamino)ethylamino] propoxy}phenylpropionate) | | CAS: | 133242-30-5 | | MF: | C25H39N3O8 | | MW: | 509.59 | | EINECS: | 1592732-453-0 | | Mol File: | 133242-30-5.mol |  |
Use
Landiolol was launched as iv infusion for the treatment of tachyarrhythmia during surgery. In clinical trials, landiolol was effective against a variety of arrhythmias with efficacy seen in patients with atrial fibrillation, proxysmal supraventricular tachycardia, ventricular tachycardia and premature complexes. Landiolol produced a doserelated pharmacokinetic behavior, has a rapid onset of action (10 min.) and is rapidly hydrolyzed to inactive acidic metabolites by esterases after iv administration.
- Landiolol
-
- US $0.00 / gram
- 2024-06-14
- CAS:133242-30-5
- Min. Order: 10gram
- Purity: 99.99
- Supply Ability: 10Tons
- Landiolol
-
- US $0.00-0.00 / g
- 2024-04-11
- CAS:133242-30-5
- Min. Order: 1g
- Purity: 99.99%
- Supply Ability: 20 tons
- Landiolol USP/EP/BP
-
- US $1.10 / g
- 2021-08-13
- CAS:133242-30-5
- Min. Order: 1g
- Purity: 99.9%
- Supply Ability: 100 Tons min
|
|
133242-30-5
Recommend Suppliers |
|